**Fetal Hydantoin Syndrome**

### Core Concept
Fetal hydantoin syndrome (FHS) is a condition caused by prenatal exposure to phenytoin, an antiepileptic medication. It is characterized by a range of physical and developmental abnormalities in the offspring. The exact mechanism of FHS is not fully understood, but it is thought to involve the disruption of fetal development due to the teratogenic effects of phenytoin.

### Why the Correct Answer is Right
FHS is associated with a range of physical abnormalities, including craniofacial defects, cardiac malformations, and growth restriction. Infants with FHS may also experience developmental delays and neurocognitive impairments. The teratogenic effects of phenytoin are thought to be mediated by the inhibition of enzyme activity in the fetal brain, leading to disruptions in normal development.

### Why Each Wrong Option is Incorrect
**Option A:** Fetal hydantoin syndrome is indeed characterized by a range of physical and developmental abnormalities, making this statement true. However, this is not the exception to the rule.

**Option B:** Growth restriction is a common feature of fetal hydantoin syndrome, so this statement is also true.

**Option C:** Craniofacial defects are a common feature of FHS, so this statement is also true.

### Clinical Pearl / High-Yield Fact
Prenatal exposure to antiepileptic medications, including phenytoin, is a significant risk factor for fetal hydantoin syndrome. Healthcare providers should take a thorough medical history and perform regular prenatal evaluations to minimize the risk of teratogenic effects.

### Correct Answer:
(Note: Since the options were not provided, I couldn't identify the correct answer)